Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Patients reported positive outcomes with use of an HIV prevention medication dosed only as needed, instead of the more common daily dosing, Kaiser Permanente researchers reported.
Black patients being treated for hepatitis C can take 8 weeks of certain direct-acting antiviral drugs rather than the previous recommendation of 12 weeks, updated guidelines say.
Listen on KP RESEARCH RADIO:
“What we learned is that contrary to recommendations from leading societies, sicker patients were more likely to be on insulin, and over time were less likely to be discontinued from their insulin.”
- Dr. Richard Grant, senior author of study in JAMA Internal Medicine.
Analysis finds that neurological side effects from the anti-seizure medication phenytoin are more common in patients with certain genetic variants that were also associated with lower adherence to treatment, suggesting they may play a role in patients finding the right medication.
The number of women using cannabis in the year before they get pregnant and early in their pregnancies is increasing, and their frequency of use is also rising, according to new data from Kaiser Permanente.
The reported rates of ischemic stroke in four large studies vary substantially, creating uncertainty about the predicted benefits of anticoagulation medication, according to new findings in Annals of Internal Medicine by Kaiser Permanente researchers and colleagues.
For patients with type 2 diabetes in usual practice, the use of the more expensive insulin analogs did not appear to result in better safety or better blood sugar control compared with NPH insulin.
By Janet Byron, Senior Communications Specialist, Division of Research This year, the KP Northern California Division of Research received an $11 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) for a series of studies on stroke prevention in…
In a recently published study, Division researchers found little evidence of increased risk of heart attack, sudden cardiac death or stroke associated with use of medications used primarily used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). The population-based study included more than…
Patients at Kaiser Permanente Northern California who got their new statin prescriptions from mail-order pharmacies showed better cholesterol control, in the first three to 15 months after starting therapy, than patients using walk-in pharmacies, according to a Kaiser Permanente Northern…
